The activity of cathepsin D in saliva of cystic fibrosis patients

Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiologi...

Full description

Saved in:
Bibliographic Details
Published inFolia histochemica et cytobiologica Vol. 45; no. 3; pp. 165 - 168
Main Authors Minarowska, Alina, Minarowski, Lukasz, Karwowska, Alicja, Sands, Dorota, Dabrowska, Ewa
Format Journal Article
LanguageEnglish
Published Poland Wydawnictwo Via Medica 01.01.2007
Via Medica
Subjects
Online AccessGet full text
ISSN0239-8508
1897-5631
DOI10.5603/4520

Cover

Loading…
Abstract Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets.
AbstractList Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets.
Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets.Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets.
Author Minarowski, Lukasz
Sands, Dorota
Dabrowska, Ewa
Minarowska, Alina
Karwowska, Alicja
Author_xml – sequence: 1
  givenname: Alina
  surname: Minarowska
  fullname: Minarowska, Alina
  email: minar@mp.pll
  organization: 3rd Department of Children's Diseases, Medical University of Białystok, Poland. minar@mp.pll
– sequence: 2
  givenname: Lukasz
  surname: Minarowski
  fullname: Minarowski, Lukasz
– sequence: 3
  givenname: Alicja
  surname: Karwowska
  fullname: Karwowska, Alicja
– sequence: 4
  givenname: Dorota
  surname: Sands
  fullname: Sands, Dorota
– sequence: 5
  givenname: Ewa
  surname: Dabrowska
  fullname: Dabrowska, Ewa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17951164$$D View this record in MEDLINE/PubMed
BookMark eNpdkEtrwzAQhEVJaV79C8X00JtbrV6RjyF9BQK9pGeztuRGwbFSyw7k31ckaQ-97MLsxzCzYzJofGMJmQJ9lIryJyEZvSIj0NkslYrDgIwo41mqJdVDMg5hS2kEBdyQIcwyCaDEiMzXG5tg2bmD646Jr5ISu43dB9ckz0kcAWt3wNPhGDpXJpUrWh9cSPbYOdt0YUquK6yDvb3sCfl8fVkv3tPVx9tyMV-lhlPWpSXLmFaCarBGoOaZoSZDZqSgCipmS8BCKxAKGegCyyhVUnOjpeCqtJpPyPLsazxu833rdtgec48uPwm-_cqxjQlrmxdWm1hRMKxAFHKGWnJqGYXKxixGRq-Hs9e-9d-9DV2-c6G0dY2N9X3IlRbAQPII3v8Dt75vm9gzZ8BpJvgMInR3gfpiZ81ftt8v8x-vI3tZ
ContentType Journal Article
Copyright Copyright Folia Histochemica et Cytobiologica 2007
Copyright_xml – notice: Copyright Folia Histochemica et Cytobiologica 2007
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
4T-
7QL
7QP
7T5
7TK
7TO
7U7
7X7
7XB
88A
88E
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BYOGL
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
DOA
DOI 10.5603/4520
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Docstoc
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
East Europe, Central Europe Database (ProQuest)
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Docstoc
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central Basic
Toxicology Abstracts
East Europe, Central Europe Database
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BYOGL
  name: East Europe, Central Europe Database (ProQuest)
  url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/eastcentraleurope
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1897-5631
EndPage 168
ExternalDocumentID oai_doaj_org_article_be8d17942af14b57a8530e201fe302d5
1372797561
17951164
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
29H
2WC
36B
3EA
53G
5GY
5VS
7X7
88E
8AO
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
ABMXE
ABUWG
ACIHN
ACPRK
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BYOGL
C1A
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
DWQXO
E3Z
EBD
EBS
ECM
EIF
EJD
EMB
EMOBN
EOJEC
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HH5
HMCUK
IPNFZ
KQ8
LK8
M1P
M2O
M7P
NPM
OBODZ
OK1
P2P
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
Q2X
RIG
RNS
SV3
TR2
UKHRP
Y2W
ZXP
~02
3V.
4T-
7QL
7QP
7T5
7TK
7TO
7U7
7XB
88A
8FD
8FK
C1K
FR3
H94
K9.
MBDVC
OVT
P64
PHGZM
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
RC3
7X8
PUEGO
ID FETCH-LOGICAL-d302t-c292864081ed4a839d0d9a2d54061f2ec1ab86146a218bacf2ef583d85436ce83
IEDL.DBID DOA
ISSN 0239-8508
IngestDate Wed Aug 27 01:21:49 EDT 2025
Fri Jul 11 13:06:09 EDT 2025
Fri Jul 25 10:51:56 EDT 2025
Thu Apr 03 07:00:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d302t-c292864081ed4a839d0d9a2d54061f2ec1ab86146a218bacf2ef583d85436ce83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/be8d17942af14b57a8530e201fe302d5
PMID 17951164
PQID 213094371
PQPubID 34373
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_be8d17942af14b57a8530e201fe302d5
proquest_miscellaneous_68412153
proquest_journals_213094371
pubmed_primary_17951164
PublicationCentury 2000
PublicationDate 2007-01-01
PublicationDateYYYYMMDD 2007-01-01
PublicationDate_xml – month: 01
  year: 2007
  text: 2007-01-01
  day: 01
PublicationDecade 2000
PublicationPlace Poland
PublicationPlace_xml – name: Poland
– name: Bialystok
PublicationTitle Folia histochemica et cytobiologica
PublicationTitleAlternate Folia Histochem Cytobiol
PublicationYear 2007
Publisher Wydawnictwo Via Medica
Via Medica
Publisher_xml – name: Wydawnictwo Via Medica
– name: Via Medica
SSID ssj0056041
Score 1.7698934
Snippet Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of...
SourceID doaj
proquest
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 165
SubjectTerms Adolescent
Cathepsin D - analysis
Cathepsin D - metabolism
Cystic Fibrosis - enzymology
Excretion
Female
Humans
Male
Reference Standards
Saliva - chemistry
Saliva - enzymology
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8QgEJ74iMaYGN-u64OD18aWAqUn42uzMdGTm-ytgQLGy3a168F_7wyte9NLD5BQwgzzAr4P4MpnxijhUXlNJojCTCU2lDJRuhBBqtraWBp4flHjiXiayml_N6ftr1X-2sRoqF1TU438mqOxLUVeZDfzj4RIo-hwtWfQWIV1Qi6j3KuYLvMt9OWRuJKebyYaA5FN2EYbgc35tZBE8B1R-v8OLaOLGe3CTh8bsttOmHuw4mf7sNGxRX4fwC2KlNE7BKJ7YE1gEXJ1jsk-e2D4aQ0d68SOb0JfZgFT4aZ9b1kPntoewmT0-Ho_TnoGhMTlKV8kNS-5VgLdtnfCYCzjUlca7iS54cB9nRmr0cEqg57amhqbgtS501LkqvY6P4K1WTPzJ8CMNYXjqeQoNRGCKG1qPc98Kp3nss4GcEerUc07kIuKYKdjQ_P5VvVaXFmvHe1gbkImrCwMOvvUYwwRPM7XyQEMf9ey6vdCWy0lN4DLZS8qMZ1MmJlvvtpKaUEoF_kAjjsBLKeBf8OQUInTf0cewlZXc6XSyBmsLT6__DkGCwt7EVXiB_QHvPk
  priority: 102
  providerName: ProQuest
Title The activity of cathepsin D in saliva of cystic fibrosis patients
URI https://www.ncbi.nlm.nih.gov/pubmed/17951164
https://www.proquest.com/docview/213094371
https://www.proquest.com/docview/68412153
https://doaj.org/article/be8d17942af14b57a8530e201fe302d5
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwED1BEQghIb4pheKBNWri2I4zUmhVIVEhRKVukR3bEktbkXbov-fspBULYmHJYA8--y5-56_3AB5sopRgFoNXJcxLmIlIu5xHQmbMcVFqHbYGXsdiNGEvUz79IfXl74TV9MD1wPW0lcYHDVUuYZpnCvEltghbzqYxNYG9FDFvs5iq52CE8aBZ6V9uRhJzkAM4wukBi9Me417bOxD0_55VBnQZnsBxkxaSx9qcU9ixszPYr4Ui1-fwiN4k_gmCV3ogc0cC2-oC1_nkmeCnUv5EJ1SsPfEycbgKnlefFWl4U6sLmAwHH0-jqBE_iAz2axmVNKdSMERsa5jCNMbEJlfYYY_AjtoyUVoitgqFIK1ViUWOy9RIzlJRWpleQms2n9lrIEqrzNCYU3QYc47lOtaWJjbmxlJeJm3o-9EoFjW_ReEZp0MB-qFo_FD85Yc2dDZjWTS_QVVQRMicpRk2cb-txfj1hxJqZuerqhCSeYKLtA1XtQO2ZmBrmA0KdvMf5nXgsN6V9Zsnt9Bafq3sHaYTS92F3WyadWGvPxi_vXdDHH0Da8jIEg
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV3NTtwwEB7BIihCaiktdKEtPtBjIHFsr3PgAAW6lAUuINFTsGO7WiEliOyqWh6FV-HlGOdnD0jlhsQlB1tynMx45vN4PB_Alo2UEsyi8qqIeQozEWiX8EDIHnNcZFpXoYHTM9G_ZL-v-NUMPLR3YXxaZWsTK0NtiszHyHcoGtuExb2oSaA8sZN_uD0rd48PUJY_KD06vPjZDxoGgcDEIR0FGU2oFAzdnjVMIRYwoUkUNdy7MUdtFikt0UEJhZ5OqwybHJexkZzFIrMyxnFnYQ43FZR1YG7_z_mvQWvnESpUvJj-dmggEecswBKaIGyOdxj3_OEVCcD_kWvlwY4-wGP77XXiys32eKS3s_tnZSHf5s9ZhvcNcCZ7taZ_hBmbr8B8TaU5-QR7qO_EX9LwXBikcKSqR3tbDnNyQPBRKn_mVXVMfGlq4oYaAcKwJE1l2fIzXL7K_Fehkxe5_QJEadUzNOQUVZo5xxIdaksjG3JjKc-iLux7Waa3dQWQ1NfkrhqKu79ps8RTbaXx5o0qFzHNewqRUGgRYDmL8zW8Cxut8NLGUJTpVHJd2Jz24gr3xzYqt8W4TIVkvgRI3IW1Wn2m08C3IV4WbP3FkTfhXf_idJAOjs9ONmCxDk77GNJX6IzuxvYboqqR_t6oN4Hr11aaJwbgLgc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+activity+of+cathepsin+D+in+saliva+of+cystic+fibrosis+patients&rft.jtitle=Folia+histochemica+et+cytobiologica&rft.au=Minarowska%2C+Alina&rft.au=Minarowski%2C+Lukasz&rft.au=Karwowska%2C+Alicja&rft.au=Sands%2C+Dorota&rft.date=2007-01-01&rft.issn=0239-8508&rft.volume=45&rft.issue=3&rft.spage=165&rft_id=info:doi/10.5603%2F4520&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0239-8508&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0239-8508&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0239-8508&client=summon